JMO, but I don’t believe BO is the intent of the company. I think they want to keep cancer and NPs interview hinted at such. He said something along the lines of expecting the share price to explode with NASH partnership, cancer and BLA approval. I initially thought he said partnership for NASH and cancer but when I listened again I believe it was meant as three upcoming catalysts to explode the share price (and I agree with).

Looking forward to how soon they get BLA filed and more TNBC patients enrolled and further confirmation for BTD.